Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2016

01-08-2016 | Short Research Report

Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes

Authors: Ian Ellul, Victor Grech, Simon Attard-Montalto

Published in: International Journal of Clinical Pharmacy | Issue 4/2016

Login to get access

Abstract

Background Reviews of paediatric prescriptions in the community setting have quantified off-label use to reach 52 % and unlicensed use to reach 17 %. Objective To investigate the attitudes and perceptions of a sample of paediatricians and family doctors practising in primary care on off-label and unlicensed prescribing in children in Malta. Methods A validated de novo 18-item questionnaire was used to conduct face-to-face, semi-structured interviews with 24 family doctors and 6 paediatricians during 2014. Results Although only 10 % of participants correctly defined off-label/unlicensed use, after the definitions were provided, 97 % admitted to knowingly prescribe medicines in this manner. Such use primarily involved prescribing to younger age groups and different indications to those recommended in the product literature. The main contributing factor for prescribing in an off-label/unlicensed manner was a lack of appropriately licensed paediatric medicines. The most commonly implicated class of medicines was cough/cold medicines. The principal concerns were medico-legal and safety concerns. Conclusion Participants knowingly prescribed medicines in an off-label/unlicensed manner. The perceived reasons were prescribing for a younger age and for indications outside the Summary of Product Characteristics. Divergent prescribing recommendations in different sources of information, prescribers’ personal experience and reliance on medical representatives contribute to inadvertent off-label/unlicensed prescribing.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164:552–8.CrossRefPubMed Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164:552–8.CrossRefPubMed
2.
go back to reference Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5:703–18.CrossRefPubMed Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5:703–18.CrossRefPubMed
3.
go back to reference Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796–801.CrossRefPubMed Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther. 2012;91(5):796–801.CrossRefPubMed
4.
go back to reference Ellul IC, Grech V, Attard-Montalto S. Paediatric off-label and unlicensed prescribing in primary care in Malta: prospective observational drug utilisation study. Int J Risk Saf Med. 2015;27(3):123–34.CrossRefPubMed Ellul IC, Grech V, Attard-Montalto S. Paediatric off-label and unlicensed prescribing in primary care in Malta: prospective observational drug utilisation study. Int J Risk Saf Med. 2015;27(3):123–34.CrossRefPubMed
5.
go back to reference Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off-label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol. 2005;60(2):145–9.CrossRefPubMedPubMedCentral Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off-label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol. 2005;60(2):145–9.CrossRefPubMedPubMedCentral
6.
go back to reference McLay JS, Tanaka M, Ekins-Daukes S, Helms PJ. A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians. Arch Dis Child. 2006;91:584–7.CrossRefPubMedPubMedCentral McLay JS, Tanaka M, Ekins-Daukes S, Helms PJ. A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians. Arch Dis Child. 2006;91:584–7.CrossRefPubMedPubMedCentral
7.
go back to reference Marchetti F, Bua J, Ventura A, Notarangelo LD, Di Maio S, Migliore G, et al. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals. Eur J Clin Pharmacol. 2007;63:81–5.CrossRefPubMed Marchetti F, Bua J, Ventura A, Notarangelo LD, Di Maio S, Migliore G, et al. The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals. Eur J Clin Pharmacol. 2007;63:81–5.CrossRefPubMed
8.
go back to reference Mukattash TL, Wazaify M, Khuri-Boulos N, Jarab A, Hawwa AF, McElnay JC. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. Int J Clin Pharm. 2011;33(6):964–73.CrossRefPubMed Mukattash TL, Wazaify M, Khuri-Boulos N, Jarab A, Hawwa AF, McElnay JC. Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribing. Int J Clin Pharm. 2011;33(6):964–73.CrossRefPubMed
9.
go back to reference Piñeiro-Pérez R, Ruiz Antorán MB, Avendaño Solá C, Román Riechmann E, Cabrera García L, Cilleruelo Ortega MJ, et al. Results from the 2012–2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study). An Pediatr (Barc). 2014;81(1):16–21.CrossRefPubMed Piñeiro-Pérez R, Ruiz Antorán MB, Avendaño Solá C, Román Riechmann E, Cabrera García L, Cilleruelo Ortega MJ, et al. Results from the 2012–2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study). An Pediatr (Barc). 2014;81(1):16–21.CrossRefPubMed
10.
go back to reference Chisholm A. Exploring UK attitudes towards unlicensed medicines use: a questionnaire-based study of members of the general public and physicians. Int J Gen Med. 2012;5:27–40.PubMedPubMedCentral Chisholm A. Exploring UK attitudes towards unlicensed medicines use: a questionnaire-based study of members of the general public and physicians. Int J Gen Med. 2012;5:27–40.PubMedPubMedCentral
11.
go back to reference Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol. 2011;67(5):449–61.CrossRefPubMed Mukattash T, Hawwa AF, Trew K, McElnay JC. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol. 2011;67(5):449–61.CrossRefPubMed
12.
go back to reference Carnovale C, Conti V, Perrone V, Antoniazzi S, Pozzi M, Merlino L, et al. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr. 2013;172(12):1679–85.CrossRefPubMed Carnovale C, Conti V, Perrone V, Antoniazzi S, Pozzi M, Merlino L, et al. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr. 2013;172(12):1679–85.CrossRefPubMed
13.
go back to reference Bua J, L’Erario I, Barbi E, Marchetti F. When off-label is a good practice: the example of paracetamol and salbutamol. Arch Dis Child. 2008;93:546–7.CrossRefPubMed Bua J, L’Erario I, Barbi E, Marchetti F. When off-label is a good practice: the example of paracetamol and salbutamol. Arch Dis Child. 2008;93:546–7.CrossRefPubMed
Metadata
Title
Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes
Authors
Ian Ellul
Victor Grech
Simon Attard-Montalto
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0306-5

Other articles of this Issue 4/2016

International Journal of Clinical Pharmacy 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine